(Total Views: 213)
Posted On: 12/20/2019 6:44:42 AM
Post# of 250662
$PBIO Dr. Tom Conrads group highlighted their new workflow that they said could enable the ID of biomarkers associated with women’s cancers and possible significantly improve the clinical management of gynecological cancers…their workflow uses the PCT platform.
Dr. Tom Conrads is an expert in women’s health and a global key opinion leader in proteomics and cancer.
35,000 women die/year from gynecologic (e.g., ovarian, uterine, and cervical) cancers; new detection methods & treatments are vitally needed.
Global ovarian cancer diagnostic market alone forecasted to reach $1.8 billion by 2026.
#stocks
Dr. Tom Conrads is an expert in women’s health and a global key opinion leader in proteomics and cancer.
35,000 women die/year from gynecologic (e.g., ovarian, uterine, and cervical) cancers; new detection methods & treatments are vitally needed.
Global ovarian cancer diagnostic market alone forecasted to reach $1.8 billion by 2026.
#stocks
(0)
(0)
